These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 8704492)

  • 41. Combination of CBT with fluoxetine works better for obsessive-compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP
    Asian J Psychiatr; 2012 Mar; 5(1):113. PubMed ID: 26878959
    [No Abstract]   [Full Text] [Related]  

  • 42. Myth of the pure obsessional type in obsessive--compulsive disorder.
    Williams MT; Farris SG; Turkheimer E; Pinto A; Ozanick K; Franklin ME; Liebowitz M; Simpson HB; Foa EB
    Depress Anxiety; 2011 Jun; 28(6):495-500. PubMed ID: 21509914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine.
    Kampman M; Keijsers GP; Hoogduin CA; Verbraak MJ
    Acta Psychiatr Scand; 2002 Oct; 106(4):314-9. PubMed ID: 12225499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treating obsessive compulsive disorder.
    Veale D
    Practitioner; 2002 Mar; 246(1632):181, 184-6. PubMed ID: 11901781
    [No Abstract]   [Full Text] [Related]  

  • 45. [To identify and treat obsessive-compulsive disorders: an overview].
    Voderholzer U; Hauer M; Stattrop U
    MMW Fortschr Med; 2013 Sep; 155(15):37-9. PubMed ID: 24224373
    [No Abstract]   [Full Text] [Related]  

  • 46. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
    Bloch MH; Storch EA
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment and medication management of paediatric obsessive-compulsive disorder.
    Stewart SE; Hezel D; Stachon AC
    Drugs; 2012 May; 72(7):881-93. PubMed ID: 22564131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of obsessive compulsive disorder in the elderly: a review and case example.
    Calamari JE; Faber SD; Hitsman BL; Poppe CJ
    J Behav Ther Exp Psychiatry; 1994 Jun; 25(2):95-104. PubMed ID: 7983229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Childhood Obsessive-Compulsive Disorder.
    Schuyler M; Geller DA
    Psychiatr Clin North Am; 2023 Mar; 46(1):89-106. PubMed ID: 36740357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The nature, assessment, and treatment of obsessive-compulsive disorder.
    McGuire JF; Lewin AB; Horng B; Murphy TK; Storch EA
    Postgrad Med; 2012 Jan; 124(1):152-65. PubMed ID: 22314125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obsessive-compulsive disorder in children and adolescents.
    Krebs G; Heyman I
    Arch Dis Child; 2015 May; 100(5):495-9. PubMed ID: 25398447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II.
    Conelea CA; Walther MR; Freeman JB; Garcia AM; Sapyta J; Khanna M; Franklin M
    J Am Acad Child Adolesc Psychiatry; 2014 Dec; 53(12):1308-16. PubMed ID: 25457929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
    Krebs G; Isomura K; Lang K; Jassi A; Heyman I; Diamond H; Advani J; Turner C; Mataix-Cols D
    Br J Clin Psychol; 2015 Mar; 54(1):63-75. PubMed ID: 25130442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis.
    Öst LG; Riise EN; Wergeland GJ; Hansen B; Kvale G
    J Anxiety Disord; 2016 Oct; 43():58-69. PubMed ID: 27632568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obsessive-compulsive disorders.
    Thomsen PH
    Eur Child Adolesc Psychiatry; 2013 Feb; 22 Suppl 1():S23-8. PubMed ID: 23208425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypochondriasis: conceptualization, treatment, and relationship to obsessive compulsive disorder.
    Abramowitz JS
    Ann Clin Psychiatry; 2005; 17(4):211-7. PubMed ID: 16402753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EEG-arousal regulation as predictor of treatment response in patients suffering from obsessive compulsive disorder.
    Dohrmann AL; Stengler K; Jahn I; Olbrich S
    Clin Neurophysiol; 2017 Oct; 128(10):1906-1914. PubMed ID: 28826021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
    Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention.
    Zandberg LJ; Zang Y; McLean CP; Yeh R; Simpson HB; Foa EB
    Behav Res Ther; 2015 May; 68():76-81. PubMed ID: 25824533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obsessive-compulsive disorder: a critical review of therapeutic perspectives.
    Schruers K; Koning K; Luermans J; Haack MJ; Griez E
    Acta Psychiatr Scand; 2005 Apr; 111(4):261-71. PubMed ID: 15740462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.